Amphastar Pharmaceuticals Inc. recently presented at the Jefferies Global Healthcare Conference, detailing its comprehensive business strategy and operational capabilities. The company highlighted its one-stop, fully integrated business model that encompasses research and development, manufacturing, and distribution. Amphastar's growth strategy is driven by pipeline development and strategic acquisitions, with a focus on high quality, high efficiency, and high technology. The company also emphasized its extensive in-house product development capabilities, including technical platforms, state-of-the-art instruments, and clinical research. Furthermore, Amphastar maintains control over quality and compliance throughout the product development and manufacturing cycle. You can access the full presentation through the link below.